In this article, we review the literature on the current advances in targeted therapies for metastatic gastric cancer aimed at improving patient care. We conclude that the key to guiding targeted therapy is individual ...

The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic HER2-positive breast cancer. The combination of trastuzumab with a taxane as first-line treatment in HER2-positive ...

The use of targeted therapy directed against HER2 is currently the standard of care in patients with metastatic HER2-positive breast cancer. The combination of trastuzumab with a taxane as first-line treatment in HER2-positive ...

Aims: To test the hypothesis that ages above 54 years not included in the national program and a greater proportion of advanced stages in the public health sector that attends 75% of the population, could explain the ...

Nanoparticles as drug delivery systems and diagnostic agents have gained much attention in recent years, especially for cancer treatment. Nanocarriers improve the therapeutic efficiency and bioavailability of antitumor ...

Conclusiones La pRTUP es una buena opción de tratamiento para la desobstrucción al tracto de salida de la vejiga secundaria al adenocarcinoma de próstata localmente avanzado, con mejoría considerable de los síntomas urinarios ...